Poster 48
- Kelley Tangredi
- May 2, 2024
- 1 min read
Updated: Jun 27, 2024
A Phase 2b, Long-term Extension, Dose-ranging Study of Oral JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis: FRONTIER-2
Authors: L.K. Ferris, J. Bagel, Y-H. Huang3 A. Pink, S.K. Tyring, G. Kokolakis, A.M. DeLozier, S. Li, Y.-K. Shen, T. Ota, R. Bissonnette

Poster 48